Sinus Aspiration against Contrast Induced Kidney Injury: Yes or No?

Sinus Aspiration against Contrast Induced Kidney InjuryContrast induced kidney injury incidence is in direct correlation to the administered contrast. The aim of this study was to assess the safety and efficacy of sinus aspiration immediately after PCI as a measure to reduce the volume of contrast arriving in the kidneys.

 

The study included 43 patients with diabetes and renal impairment (creatinine between 1.5 and 3 mg/dL) that were candidates for a coronary angiography.

 

Sinus aspiration was performed in 18 patients out of 43, and the rest served as control group. All patients received periprocedural standard care.

 

Aspiration was done directly from a trans-septal sheath via femoral or subclavian approach in 8 patients; other 10 patients were accessed through a balloon occlusion catheter placed through the sheath simultaneously during coronary angiography.

 

The estimated contrast volume aspirated was based on the reduction in hematocrit value of the aspirate (reduced by contrast) in relation to the patient’s baseline hematocrit.  Fraction of aspirated contrast was calculated by dividing the estimated volume of aspirated contrast over the volume of injected contrast multiplied by 100.

 

Both the group receiving coronary sinus aspiration and the control group resulted similar as to clinical and lab characteristics, as well as administered contrast.

 

In the active group, aspirated contrast fraction was 39.35 ± 10.47%. Only one patient in the coronary sinus aspiration group, vs. 9 patients in the control group, presented contrast induced kidney injury (p=0.028).

 

Conclusion

Coronary sinus aspiration during coronary angiography can effectively remove up to a third of the administered contrast, reducing contrast kidney injury in selected patients.

 

Editorial Comment

This maneuver appears to be simple and logical; in fact, after reading Dr Diab’s work, most of us might have thought “how come we didn’t think of this before”.

 

This study does not report important complications, and contrast induced kidney injury reduction rate is quite significant; however, more definite conclusions call for a larger, more important study.

 

Original Title: Efficacy and Safety of Coronary Sinus Aspiration during Coronary Angiography to Attenuate the Risk of Contrast-Induced Acute Kidney Injury in Predisposed Patients.

Reference: Osama Ali Diab et al. Circ Cardiovasc Interv. 2017 Jan;10(1):e004348.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

ACC 2026 | CHIP-BCIS3: Impella use as support in high-risk complex PCI

The use of percutaneous ventricular support during high-risk complex PCI has been proposed as a strategy to prevent hemodynamic deterioration in patients with severe...

ACC 2026 | ORBITA-CTO: PCI in chronic total occlusions and stable angina — the randomized trial we were missing?

Percutaneous coronary intervention (PCI) for chronic total occlusions (CTO) remains a topic of ongoing debate in stable angina, with persistent uncertainty regarding its role...

ACC 2026 | FAST III: vFFR vs FFR in physiology-guided revascularization of intermediate coronary lesions

Physiological assessment of intermediate coronary lesions remains a cornerstone in decision-making for coronary revascularization. Although FFR continues to be one of the guideline-recommended references,...

ACC 2026 | STEMI-Door To Unload: Unloading with Impella before PCI did not reduce infarct size in anterior STEMI

Anterior ST-segment elevation myocardial infarction (STEMI) remains associated with a high incidence of heart failure and mortality, even in the era of early reperfusion....

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

ACC 2026 | CHIP-BCIS3: Impella use as support in high-risk complex PCI

The use of percutaneous ventricular support during high-risk complex PCI has been proposed as a strategy to prevent hemodynamic deterioration in patients with severe...

ACC 2026 | ORBITA-CTO: PCI in chronic total occlusions and stable angina — the randomized trial we were missing?

Percutaneous coronary intervention (PCI) for chronic total occlusions (CTO) remains a topic of ongoing debate in stable angina, with persistent uncertainty regarding its role...

ACC 2026 | FAST III: vFFR vs FFR in physiology-guided revascularization of intermediate coronary lesions

Physiological assessment of intermediate coronary lesions remains a cornerstone in decision-making for coronary revascularization. Although FFR continues to be one of the guideline-recommended references,...